Drug intelligence / Profile preview

EquineVet Acemannan Wound Cleanser

Development stage
Unknown
Lead developer
Carrington Laboratory
Administration
Topical
01

Overview

EquineVet Acemannan Wound Cleanser is a veterinary topical wound care product developed by Carrington Laboratories. Its active ingredient is acemannan, a complex polymeric acetylated mannan derived from the *Aloe barbadensis Miller* (aloe vera) plant. The product is specifically formulated for use in horses, dogs, cats, and other companion animals to facilitate wound healing. It functions by mechanically removing organic material, debris, and necrotic tissue from the wound site using an optimized spray pressure of approximately 12 P.S.I. Beyond mechanical cleansing, the acemannan component acts as an immunomodulator, stimulating immune cells to release essential cytokines such as Tumor Necrosis Factor (TNF), Interleukin-1 (IL-1), and Interleukin-6 (IL-6). This biological activity helps regulate the wound environment and is particularly useful in managing extremity wounds in horses, where it helps prevent the formation of hyper-granulation tissue, commonly known as proud flesh.

Brand names
EquineVet Acemannan Wound Cleanser
Other names
Acemannan Wound Cleanser
02

Targets

IL1A (Interleukin 1 alpha)IL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on EquineVet Acemannan Wound Cleanser.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EquineVet Acemannan Wound Cleanser.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call